What antibiotics should I give for an adult with a blood culture positive for Enterococcus faecalis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Enterococcus faecalis Bacteremia

For blood cultures positive for Enterococcus faecalis, start ampicillin 2 g IV every 4 hours plus gentamicin 3 mg/kg/day IV in 3 divided doses, pending susceptibility results. 1, 2

Initial Empiric Therapy

  • Ampicillin is the gold standard first-line agent for E. faecalis because most strains (97%) remain ampicillin-susceptible, unlike E. faecium which has intrinsic penicillin resistance 2
  • Add gentamicin for synergistic bactericidal activity in serious bloodstream infections 1
  • Target gentamicin peak levels of 3-4 μg/mL and trough <1 μg/mL 1

Duration of Therapy Based on Source

For uncomplicated bacteremia without endocarditis:

  • Treat for 10-14 days 3

If endocarditis is present or suspected:

  • Native valve: 4-6 weeks depending on symptom duration before diagnosis (4 weeks if <3 months of symptoms, 6 weeks if ≥3 months) 1
  • Prosthetic valve: minimum 6 weeks 1

Alternative Regimens When Standard Therapy Cannot Be Used

For patients with penicillin allergy (documented by skin testing):

  • Vancomycin 30 mg/kg/day IV in 2 divided doses (target trough 10-20 μg/mL) plus gentamicin 3 mg/kg/day for 6 weeks 1
  • Note: Ampicillin-gentamicin is superior to vancomycin-gentamicin and has lower nephrotoxicity/ototoxicity risk 1
  • Consider penicillin desensitization for true life-threatening infections requiring optimal therapy 4

For high-level aminoglycoside resistance (HLAR):

  • Ampicillin 200 mg/kg/day IV in 4-6 divided doses PLUS ceftriaxone 2 g IV every 12 hours for 6 weeks 1
  • This double β-lactam regimen avoids aminoglycoside toxicity and is equally effective 1
  • The ampicillin-ceftriaxone combination showed no nephrotoxicity versus 23% with ampicillin-gentamicin 1

For streptomycin-susceptible, gentamicin-resistant strains:

  • Ampicillin 2 g IV every 4 hours plus streptomycin 15 mg/kg/day IV or IM in 2 divided doses (target peak 20-35 μg/mL, trough <10 μg/mL) 1
  • Avoid streptomycin if creatinine clearance <50 mL/min due to irreversible ototoxicity risk 1

For β-lactamase-producing E. faecalis (rare):

  • Ampicillin-sulbactam 3 g IV every 6 hours plus gentamicin 1

Critical Monitoring Parameters

  • Renal function and aminoglycoside levels must be monitored closely, especially in elderly patients (median age 70 years in major trials) 1
  • Consider shortening gentamicin to 2 weeks in patients with baseline renal impairment (creatinine clearance 30-50 mL/min) to reduce nephrotoxicity 1
  • Monitor vancomycin troughs if used (target 10-20 μg/mL) 1

Common Pitfalls to Avoid

  • Never use cephalosporins alone for enterococcal coverage—they have no intrinsic activity against enterococci 2
  • Do not assume E. faecium has the same susceptibility as E. faecalis—E. faecium requires vancomycin or linezolid due to intrinsic ampicillin resistance 2
  • Do not empirically use vancomycin for E. faecalis when ampicillin can be used—ampicillin is superior and vancomycin should be reserved for documented β-lactam allergy 2
  • Verify susceptibilities when available and adjust therapy accordingly 2

When to Suspect Endocarditis

  • Obtain infectious disease and cardiology consultation if bacteremia persists >72 hours, patient has prosthetic valve material, or has new cardiac murmur 1
  • Echocardiography (transesophageal preferred) should be performed to rule out endocarditis in persistent bacteremia 1
  • E. faecalis bacteremia carries 11% mortality but can reach 50% in severely ill patients 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Enterococcal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Coverage for Enterococcus faecium

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.